Skip to main content
. 2021 Oct 24;15:2363–2376. doi: 10.2147/PPA.S330371

Table 3.

Medication, Healthcare Resources and Intervention Cost [€] per Patient, Baseline and in Six Months Follow-Up [Mean (SE)] (N = 1186)

Intervention Group (n = 633) Control Group (n = 553) P value
● Baseline Cost (previous 6 months, except*)
 Prescribed medication (*previous month) 35.46 (1.86) 33.55 (1.63) 0.447
 Primary care physician visit 13.36 (1.23) 16.57 (1.25) 0.069
 Specialist physician visit 6.09 (1.03) 9.27 (1.37) 0.062
 Emergency department 7.33 (1.99) 6.42 (1.82) 0.739
 Hospital admissions 46.06 (31.95) 91.28 (29.52) 0.300
 Total baseline cost 72.85 (32.06) 124.00 (30.06) 0.447
● Medication and healthcare resources cost (sum of 6 months follow-up)
 Prescribed medication 228.35 (11.98) 209.52 (10.22) 0.239
 Primary care physician visit 19.99 (2.23) 23.51 (2.39) 0.283
 Specialist physicians visit 6.50 (1.97) 6.57 (1.40) 0.978
 Emergency department 6.69 (1.93) 12.01 (2.84) 0.114
 Hospital admissions 42.07 (17.96) 64.85 (21.02) 0.407
 Total cost in six months follow-up unadjusted 321.80 (21.24) 323.79 (24.07) 0.239
● Intervention cost (6 months follow-up)
 Time of providing service 24.92 (0.43)
 Initial investment in pharmacy 0.57
 Annual maintenance of service 1.04
 Initial training of pharmacist 0.38
 Visits of practice change facilitator to pharmacy 0.42
 Total intervention cost 27.33 (0.43)

Notes: *It should be noted that the cost of prescribed medication only corresponds to one month in the baseline, while at the end of the study the sum of cost of six months were included. Statistical tests: t-test.